Form 13-F position report

TRANSMEDICS GROUP INC

Reported by SEI INVESTMENTS COMPANY

TMDX 1.5 06/01/28 CUSIP 89377MAB5 Manager CIK 0000350894

Reported 248,000 shares, down 96,000 (27.9%) from the prior quarter.

Reported value -59.7%; share count -27.9% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2024
Shares 248,000 Quarter-end amount reported
Reported value $255,780 Fair value at quarter end
Consecutive quarters held 3 Through Q4 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-06-30 671645
2024-09-30 634198
2024-12-31 255780
2025-03-31 94318
2025-06-30 84911
2025-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for TRANSMEDICS GROUP INC held by SEI INVESTMENTS COMPANY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2025 Reduced 0 -53,000 (-100.0%) 0 $0 2025-11-13
Q2 2025 Reduced 53,000 -35,000 (-39.8%) < 0.01% $84,911 2025-08-14
Q1 2025 Reduced 88,000 -160,000 (-64.5%) < 0.01% $94,318 2025-05-13
Q4 2024 Reduced 248,000 -96,000 (-27.9%) < 0.01% $255,780 2025-02-11
Q3 2024 Reduced 344,000 -39,000 (-10.2%) < 0.01% $634,198 2024-11-12
Q2 2024 New 383,000 +383,000 (0.0%) < 0.01% $671,645 2024-08-13

Who else reported the position

60 managers reported TRANSMEDICS GROUP INC for Q4 2024.

Managers reporting TRANSMEDICS GROUP INC in Q4 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Linden Advisors LP Added 158,074,000 +25,832,000 1.35% $163,285,113 3 qtrs
READYSTATE ASSET MANAGEMENT LP Reduced 41,237,000 -7,463,000 1.31% $42,685,310 3 qtrs
LAZARD ASSET MANAGEMENT LLC Added 33,572,000 +5,297,000 0.05% $34,751,000 3 qtrs
MACKAY SHIELDS LLC Reduced 31,394,000 -12,579,000 0.96% $32,489,600 3 qtrs
WOLVERINE ASSET MANAGEMENT LLC Unchanged 0 0 0.32% $32,388,192 3 qtrs
FMR LLC Unchanged 0 0 < 0.01% $25,811,105 3 qtrs
Sculptor Capital LP Unchanged 22,500,000 0 0.31% $23,181,750 3 qtrs
D E Shaw & Co Inc Added 20,500,000 +3,500,000 0.02% $21,161,651 2 qtrs
STATE STREET CORPORATION Added 10,420,000 +1,000,000 < 0.01% $10,722,115 3 qtrs
Bank of America Corporation Added 9,650,000 +6,463,000 < 0.01% $9,952,720 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2024
Filed
February 11, 2025
Filing type
13F-HR
Position type
NOTE 1.500% 6/0

Voting authority reported

Sole
248,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.